Viewing Study NCT05054751

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-02-06 @ 5:56 AM
Study NCT ID: NCT05054751
Status: COMPLETED
Last Update Posted: 2024-10-10
First Post: 2021-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Sponsor: Genor Biopharma Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced or Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CDK4/6 View
None Phase III View
None GB491 View